Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study.

ABSTRACT:

Objective

To determine treatment persistence and exacerbations in patients initiating inhaler treatment with fixed-dose combinations of inhaled corticosteroids/long-acting beta-2-adrenergic agonists (ICS/LABA) for the treatment of asthma.

Design

Retrospective observational study conducted by review of electronic medical records (database: Fundación RediSS).

Setting

Retrospective cohort study. The follow-up period was 1 year.

Participants

The study included patients aged ≥18 years who started treatment with ICS/LABA and met the inclusion/exclusion criteria.

Main outcomes and measures

The study groups were fluticasone propionate/salmeterol (FP/SAL), beclomethasone/formoterol (BDP/FORM), budesonide/formoterol (BUD/FORM), fluticasone furoate/vilanterol (FF/V

SUBMITTER: Sicras-Mainar A 

PROVIDER: S-EPMC9021812 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature